25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Rocket Pharmaceuticals Inc
Buy, Hold or Sell?

Let's analyze Rocket Pharmaceuticals Inc together

I guess you are interested in Rocket Pharmaceuticals Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Rocket Pharmaceuticals Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Rocket Pharmaceuticals Inc

I send you an email if I find something interesting about Rocket Pharmaceuticals Inc.

1. Quick Overview

1.1. Quick analysis of Rocket Pharmaceuticals Inc (30 sec.)










1.2. What can you expect buying and holding a share of Rocket Pharmaceuticals Inc? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€4.01
Expected worth in 1 year
€2.99
How sure are you?
28.6%

+ What do you gain per year?

Total Gains per Share
€-1.02
Return On Investment
-12.8%

For what price can you sell your share?

Current Price per Share
€7.96
Expected price per share
€0 - €10.81
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Rocket Pharmaceuticals Inc (5 min.)




Live pricePrice per Share (EOD)
€7.96
Intrinsic Value Per Share
€-14.37 - €-16.31
Total Value Per Share
€-10.36 - €-12.30

2.2. Growth of Rocket Pharmaceuticals Inc (5 min.)




Is Rocket Pharmaceuticals Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$463.2m$473.8m-$69m-17.1%

How much money is Rocket Pharmaceuticals Inc making?

Current yearPrevious yearGrowGrow %
Making money-$64.6m-$61.3m-$3.2m-5.1%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Rocket Pharmaceuticals Inc (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Rocket Pharmaceuticals Inc?

Welcome investor! Rocket Pharmaceuticals Inc's management wants to use your money to grow the business. In return you get a share of Rocket Pharmaceuticals Inc.

First you should know what it really means to hold a share of Rocket Pharmaceuticals Inc. And how you can make/lose money.

Speculation

The Price per Share of Rocket Pharmaceuticals Inc is €7.958. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Rocket Pharmaceuticals Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Rocket Pharmaceuticals Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €4.01. Based on the TTM, the Book Value Change Per Share is €-0.25 per quarter. Based on the YOY, the Book Value Change Per Share is €-0.17 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Rocket Pharmaceuticals Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.57-7.1%-0.69-8.6%-0.72-9.1%-0.73-9.2%-0.73-9.2%
Usd Book Value Change Per Share0.739.2%-0.28-3.5%-0.18-2.3%0.313.9%0.313.9%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.739.2%-0.28-3.5%-0.18-2.3%0.313.9%0.313.9%
Usd Price Per Share12.08-19.33-21.84-19.84-19.84-
Price to Earnings Ratio-5.33--6.98--7.69--6.83--6.83-
Price-to-Total Gains Ratio16.49--22.67--23.92--20.23--20.23-
Price to Book Ratio2.78-4.52-3.97-3.67-3.67-
Price-to-Total Gains Ratio16.49--22.67--23.92--20.23--20.23-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share8.638409
Number of shares115
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.280.31
Usd Total Gains Per Share-0.280.31
Gains per Quarter (115 shares)-31.7535.74
Gains per Year (115 shares)-127.00142.97
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-127-1370143133
20-254-2640286276
30-381-3910429419
40-508-5180572562
50-635-6450715705
60-762-7720858848
70-889-89901001991
80-1016-1026011441134
90-1143-1153012871277
100-1270-1280014301420

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.014.00.00.0%0.014.00.00.0%0.014.00.00.0%
Book Value Change Per Share1.03.00.025.0%3.09.00.025.0%4.010.00.028.6%4.010.00.028.6%4.010.00.028.6%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.014.00.0%0.00.014.00.0%0.00.014.00.0%
Total Gains per Share1.03.00.025.0%3.09.00.025.0%4.010.00.028.6%4.010.00.028.6%4.010.00.028.6%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Rocket Pharmaceuticals Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.675-0.254+138%-0.169+125%0.286+136%0.286+136%
Book Value Per Share--4.0093.931+2%5.106-21%5.119-22%5.119-22%
Current Ratio--9.2968.401+11%10.266-9%11.315-18%11.315-18%
Debt To Asset Ratio--0.1220.135-9%0.116+6%0.114+7%0.114+7%
Debt To Equity Ratio--0.1390.156-11%0.131+6%0.129+8%0.129+8%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--1124912646.0501604534492.279-30%1677723601.266-33%1422067942.344-21%1422067942.344-21%
Eps---0.522-0.633+21%-0.665+27%-0.677+30%-0.677+30%
Ev To Ebitda Ratio--infinfnan%infnan%infnan%infnan%
Ev To Sales Ratio--infinfnan%infnan%infnan%infnan%
Free Cash Flow Per Share---0.409-0.529+29%-0.575+41%-0.557+36%-0.557+36%
Free Cash Flow To Equity Per Share--1.173-0.126+111%-0.037+103%-0.124+111%-0.124+111%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---16.306--------
Intrinsic Value_10Y_min---14.370--------
Intrinsic Value_1Y_max---2.202--------
Intrinsic Value_1Y_min---2.163--------
Intrinsic Value_3Y_max---6.183--------
Intrinsic Value_3Y_min---5.912--------
Intrinsic Value_5Y_max---9.643--------
Intrinsic Value_5Y_min---8.987--------
Market Cap--1184298725.2501661671691.979-29%1734408491.766-32%1473383519.944-20%1473383519.944-20%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio1.985-40%2.7754.521-39%3.966-30%3.667-24%3.667-24%
Pe Ratio-3.811+28%-5.328-6.984+31%-7.692+44%-6.833+28%-6.833+28%
Price Per Share7.958-40%11.12517.809-38%20.121-45%18.278-39%18.278-39%
Price To Free Cash Flow Ratio-4.866+28%-6.802-8.273+22%-10.096+48%-8.720+28%-8.720+28%
Price To Total Gains Ratio11.797-40%16.492-22.670+237%-23.918+245%-20.229+223%-20.229+223%
Quick Ratio--5.1306.181-17%7.257-29%6.586-22%6.586-22%
Return On Assets---0.114-0.141+23%-0.116+2%-0.121+6%-0.121+6%
Return On Equity---0.130-0.164+26%-0.131+1%-0.137+5%-0.137+5%
Total Gains Per Share--0.675-0.254+138%-0.169+125%0.286+136%0.286+136%
Usd Book Value--463216675.048404770361.022+14%473858777.019-2%436936872.236+6%436936872.236+6%
Usd Book Value Change Per Share--0.732-0.276+138%-0.183+125%0.311+136%0.311+136%
Usd Book Value Per Share--4.3514.267+2%5.542-21%5.556-22%5.556-22%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--1221092677.2871741722191.369-30%1821168969.175-33%1543654751.414-21%1543654751.414-21%
Usd Eps---0.567-0.687+21%-0.722+27%-0.735+30%-0.735+30%
Usd Free Cash Flow---47249232.813-53894484.271+14%-52845023.522+12%-48424545.997+2%-48424545.997+2%
Usd Free Cash Flow Per Share---0.444-0.574+29%-0.625+41%-0.605+36%-0.605+36%
Usd Free Cash Flow To Equity Per Share--1.274-0.137+111%-0.041+103%-0.135+111%-0.135+111%
Usd Market Cap--1285556266.2591803744621.643-29%1882700417.812-32%1599357810.899-20%1599357810.899-20%
Usd Price Per Share8.638-40%12.07619.331-38%21.842-45%19.841-39%19.841-39%
Usd Profit---60324743.770-64684080.725+7%-61396453.687+2%-58609879.337-3%-58609879.337-3%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share--0.732-0.276+138%-0.183+125%0.311+136%0.311+136%
 EOD+2 -4MRQTTM+23 -8YOY+17 -145Y+17 -1410Y+17 -14

3.3 Fundamental Score

Let's check the fundamental score of Rocket Pharmaceuticals Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3.811
Price to Book Ratio (EOD)Between0-11.985
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than15.130
Current Ratio (MRQ)Greater than19.296
Debt to Asset Ratio (MRQ)Less than10.122
Debt to Equity Ratio (MRQ)Less than10.139
Return on Equity (MRQ)Greater than0.15-0.130
Return on Assets (MRQ)Greater than0.05-0.114
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Rocket Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose7.766
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About Rocket Pharmaceuticals Inc

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Rocket Pharmaceuticals Inc earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Rocket Pharmaceuticals Inc to the  industry mean.
  • A Net Profit Margin of 0.0% means that €0.00 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Rocket Pharmaceuticals Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
4.3.1.2. Return on Assets

Shows how efficient Rocket Pharmaceuticals Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Rocket Pharmaceuticals Inc to the  industry mean.
  • -11.4% Return on Assets means that Rocket Pharmaceuticals Inc generated €-0.11 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Rocket Pharmaceuticals Inc:

  • The MRQ is -11.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -14.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-11.4%TTM-14.1%+2.7%
TTM-14.1%YOY-11.6%-2.5%
TTM-14.1%5Y-12.1%-2.0%
5Y-12.1%10Y-12.1%0.0%
4.3.1.3. Return on Equity

Shows how efficient Rocket Pharmaceuticals Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Rocket Pharmaceuticals Inc to the  industry mean.
  • -13.0% Return on Equity means Rocket Pharmaceuticals Inc generated €-0.13 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Rocket Pharmaceuticals Inc:

  • The MRQ is -13.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -16.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-13.0%TTM-16.4%+3.3%
TTM-16.4%YOY-13.1%-3.2%
TTM-16.4%5Y-13.7%-2.7%
5Y-13.7%10Y-13.7%0.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Rocket Pharmaceuticals Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Rocket Pharmaceuticals Inc is operating .

  • Measures how much profit Rocket Pharmaceuticals Inc makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Rocket Pharmaceuticals Inc to the  industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Rocket Pharmaceuticals Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
4.3.2.2. Operating Ratio

Measures how efficient Rocket Pharmaceuticals Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to  industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are €0.00 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Rocket Pharmaceuticals Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Rocket Pharmaceuticals Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Rocket Pharmaceuticals Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to  industry mean).
  • A Current Ratio of 9.30 means the company has €9.30 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Rocket Pharmaceuticals Inc:

  • The MRQ is 9.296. The company is very able to pay all its short-term debts. +2
  • The TTM is 8.401. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ9.296TTM8.401+0.895
TTM8.401YOY10.266-1.866
TTM8.4015Y11.315-2.914
5Y11.31510Y11.3150.000
4.4.3.2. Quick Ratio

Measures if Rocket Pharmaceuticals Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Rocket Pharmaceuticals Inc to the  industry mean.
  • A Quick Ratio of 5.13 means the company can pay off €5.13 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Rocket Pharmaceuticals Inc:

  • The MRQ is 5.130. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 6.181. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ5.130TTM6.181-1.052
TTM6.181YOY7.257-1.075
TTM6.1815Y6.586-0.405
5Y6.58610Y6.5860.000
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Rocket Pharmaceuticals Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Rocket Pharmaceuticals Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Rocket Pharmaceuticals Inc to industry mean.
  • A Debt to Asset Ratio of 0.12 means that Rocket Pharmaceuticals Inc assets are financed with 12.2% credit (debt) and the remaining percentage (100% - 12.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Rocket Pharmaceuticals Inc:

  • The MRQ is 0.122. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.135. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.122TTM0.135-0.013
TTM0.135YOY0.116+0.019
TTM0.1355Y0.114+0.021
5Y0.11410Y0.1140.000
4.5.4.2. Debt to Equity Ratio

Measures if Rocket Pharmaceuticals Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Rocket Pharmaceuticals Inc to the  industry mean.
  • A Debt to Equity ratio of 13.9% means that company has €0.14 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Rocket Pharmaceuticals Inc:

  • The MRQ is 0.139. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.156. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.139TTM0.156-0.017
TTM0.156YOY0.131+0.025
TTM0.1565Y0.129+0.027
5Y0.12910Y0.1290.000
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Rocket Pharmaceuticals Inc generates.

  • Above 15 is considered overpriced but always compare Rocket Pharmaceuticals Inc to the  industry mean.
  • A PE ratio of -5.33 means the investor is paying €-5.33 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Rocket Pharmaceuticals Inc:

  • The EOD is -3.811. Based on the earnings, the company is expensive. -2
  • The MRQ is -5.328. Based on the earnings, the company is expensive. -2
  • The TTM is -6.984. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.811MRQ-5.328+1.517
MRQ-5.328TTM-6.984+1.656
TTM-6.984YOY-7.692+0.707
TTM-6.9845Y-6.833-0.151
5Y-6.83310Y-6.8330.000
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Rocket Pharmaceuticals Inc:

  • The EOD is -4.866. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -6.802. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -8.273. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.866MRQ-6.802+1.936
MRQ-6.802TTM-8.273+1.471
TTM-8.273YOY-10.096+1.824
TTM-8.2735Y-8.720+0.448
5Y-8.72010Y-8.7200.000
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Rocket Pharmaceuticals Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to industry mean).
  • A PB ratio of 2.78 means the investor is paying €2.78 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Rocket Pharmaceuticals Inc:

  • The EOD is 1.985. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.775. Based on the equity, the company is underpriced. +1
  • The TTM is 4.521. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD1.985MRQ2.775-0.790
MRQ2.775TTM4.521-1.746
TTM4.521YOY3.966+0.555
TTM4.5215Y3.667+0.854
5Y3.66710Y3.6670.000
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets527,700
Total Liabilities64,466
Total Stockholder Equity463,234
 As reported
Total Liabilities 64,466
Total Stockholder Equity+ 463,234
Total Assets = 527,700

Assets

Total Assets527,700
Total Current Assets378,183
Long-term Assets149,517
Total Current Assets
Cash And Cash Equivalents 163,635
Short-term Investments 208,701
Other Current Assets 5,847
Total Current Assets  (as reported)378,183
Total Current Assets  (calculated)378,183
+/-0
Long-term Assets
Property Plant Equipment 83,322
Goodwill 39,154
Intangible Assets 25,150
Long-term Assets Other 1,362
Long-term Assets  (as reported)149,517
Long-term Assets  (calculated)148,988
+/- 529

Liabilities & Shareholders' Equity

Total Current Liabilities40,684
Long-term Liabilities23,782
Total Stockholder Equity463,234
Total Current Liabilities
Total Current Liabilities  (as reported)40,684
Total Current Liabilities  (calculated)0
+/- 40,684
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt25,498
Long-term Liabilities  (as reported)23,782
Long-term Liabilities  (calculated)25,498
+/- 1,716
Total Stockholder Equity
Total Stockholder Equity (as reported)463,234
Total Stockholder Equity (calculated)0
+/- 463,234
Other
Capital Stock1,065
Common Stock Shares Outstanding 106,454
Net Invested Capital 463,234
Net Working Capital 337,499
Property Plant and Equipment Gross 104,575



6.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-30
> Total Assets 
530,241
497,020
460,150
431,852
417,265
551,807
514,757
461,781
598,762
566,341
499,442
446,411
393,688
527,700
527,700393,688446,411499,442566,341598,762461,781514,757551,807417,265431,852460,150497,020530,241
   > Total Current Assets 
425,069
392,059
353,848
325,771
311,131
364,060
338,033
312,074
446,865
378,222
345,159
292,725
241,754
378,183
378,183241,754292,725345,159378,222446,865312,074338,033364,060311,131325,771353,848392,059425,069
       Cash And Cash Equivalents 
245,644
232,694
130,552
187,548
196,669
140,517
64,579
45,076
225,657
55,904
35,276
38,607
65,599
163,635
163,63565,59938,60735,27655,904225,65745,07664,579140,517196,669187,548130,552232,694245,644
       Short-term Investments 
175,815
156,046
216,041
133,820
109,865
215,877
266,505
261,964
211,514
317,271
295,037
240,218
170,063
208,701
208,701170,063240,218295,037317,271211,514261,964266,505215,877109,865133,820216,041156,046175,815
       Other Current Assets 
0
0
7,255
4,403
4,597
7,666
6,949
5,034
9,694
5,047
14,846
13,900
6,092
5,847
5,8476,09213,90014,8465,0479,6945,0346,9497,6664,5974,4037,25500
   > Long-term Assets 
105,172
104,961
106,300
106,081
106,134
187,747
176,724
149,707
151,897
188,119
154,283
153,686
151,934
149,517
149,517151,934153,686154,283188,119151,897149,707176,724187,747106,134106,081106,300104,961105,172
       Property Plant Equipment 
0
0
0
0
73,510
77,645
81,090
82,925
85,679
87,590
88,084
87,539
85,765
83,322
83,32285,76587,53988,08487,59085,67982,92581,09077,64573,5100000
       Goodwill 
30,815
30,815
30,815
30,815
30,815
39,154
39,154
39,154
39,154
39,154
39,154
39,154
39,154
39,154
39,15439,15439,15439,15439,15439,15439,15439,15439,15430,81530,81530,81530,81530,815
       Long Term Investments 
0
0
0
0
0
43,276
28,957
0
0
34,320
0
0
0
0
000034,3200028,95743,27600000
       Intangible Assets 
0
0
0
0
0
25,724
25,724
25,724
25,150
25,150
25,150
25,150
25,150
25,150
25,15025,15025,15025,15025,15025,15025,72425,72425,72400000
       Long-term Assets Other 
1,334
1,343
1,343
1,343
1,354
1,340
1,340
1,362
1,372
1,372
1,362
1,362
1,362
1,362
1,3621,3621,3621,3621,3721,3721,3621,3401,3401,3541,3431,3431,3431,334
> Total Liabilities 
44,583
42,296
42,530
44,156
49,952
62,121
55,881
58,811
57,676
73,767
57,940
61,776
63,917
64,466
64,46663,91761,77657,94073,76757,67658,81155,88162,12149,95244,15642,53042,29644,583
   > Total Current Liabilities 
24,489
22,167
22,570
24,289
30,181
39,169
31,206
34,346
33,476
48,505
32,957
37,592
39,980
40,684
40,68439,98037,59232,95748,50533,47634,34631,20639,16930,18124,28922,57022,16724,489
   > Long-term Liabilities 
20,094
20,129
19,960
19,867
19,771
22,952
24,675
24,465
24,200
25,262
24,983
24,184
23,937
23,782
23,78223,93724,18424,98325,26224,20024,46524,67522,95219,77119,86719,96020,12920,094
       Capital Lease Obligations Min Short Term Debt
22,481
22,601
22,434
22,265
22,092
22,866
25,397
25,386
25,183
25,042
25,949
25,798
25,642
25,498
25,49825,64225,79825,94925,04225,18325,38625,39722,86622,09222,26522,43422,60122,481
> Total Stockholder Equity
485,658
454,724
417,620
387,696
367,313
489,686
458,876
402,970
541,086
492,574
441,502
384,635
329,771
463,234
463,234329,771384,635441,502492,574541,086402,970458,876489,686367,313387,696417,620454,724485,658
   Common Stock00000000000000
   Retained Earnings Total Equity00000000000000
   Accumulated Other Comprehensive Income 00000000000000
   Capital Surplus 00000000000000
   Treasury Stock00000000000000
   Other Stockholders Equity 00000000000000



6.3. Balance Sheets

Currency in USD. All numbers in thousands.




6.4. Cash Flows

Currency in USD. All numbers in thousands.




6.5. Income Statements

Currency in USD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-273,205
Operating Income-273,205-273,205
 
Operating Expense (+$)
Research Development171,244
Selling General Administrative101,961
Selling And Marketing Expenses0
Operating Expense273,205273,205
 
Net Interest Income (+$)
Interest Income16,345
Interest Expense-1,886
Other Finance Cost-0
Net Interest Income14,459
 
Pretax Income (+$)
Operating Income-273,205
Net Interest Income14,459
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-258,746-273,205
EBIT - interestExpense = -1,886
-258,746
-256,860
Interest Expense1,886
Earnings Before Interest and Taxes (EBIT)0-256,860
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-258,746
Tax Provision-0
Net Income From Continuing Ops-258,746-258,746
Net Income-258,746
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-14,459
 

Technical Analysis of Rocket Pharmaceuticals Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Rocket Pharmaceuticals Inc. The general trend of Rocket Pharmaceuticals Inc is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Rocket Pharmaceuticals Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Rocket Pharmaceuticals Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 9.252 < 10.48 < 10.81.

The bearish price targets are: .

Tweet this
Rocket Pharmaceuticals Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Rocket Pharmaceuticals Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Rocket Pharmaceuticals Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) ChartRocket Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Rocket Pharmaceuticals Inc. The current adx is .

Rocket Pharmaceuticals Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc Daily Relative Strength Index (RSI) ChartRocket Pharmaceuticals Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc Daily Stochastic Oscillator ChartRocket Pharmaceuticals Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc Daily Commodity Channel Index (CCI) ChartRocket Pharmaceuticals Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) ChartRocket Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc Daily Williams %R ChartRocket Pharmaceuticals Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc Daily Average True Range (ATR) ChartRocket Pharmaceuticals Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc Daily On-Balance Volume (OBV) ChartRocket Pharmaceuticals Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc Daily Money Flow Index (MFI) ChartRocket Pharmaceuticals Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Rocket Pharmaceuticals Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-10-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-10-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-11-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-11-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-11-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-11-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-14BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-21MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-22STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-03STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-09STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-12-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-12-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-18RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-01-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-01-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-17STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-23ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-01-27STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-31SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-02-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-10WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-02-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-28STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-03BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-05RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-10ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-11ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-12RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-13WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Rocket Pharmaceuticals Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Rocket Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose7.766
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Rocket Pharmaceuticals Inc with someone you think should read this too:
  • Are you bullish or bearish on Rocket Pharmaceuticals Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Rocket Pharmaceuticals Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Rocket Pharmaceuticals Inc

I send you an email if I find something interesting about Rocket Pharmaceuticals Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Rocket Pharmaceuticals Inc.

Receive notifications about Rocket Pharmaceuticals Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.